$803 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 40 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 79.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $295,053,000 | +45.9% | 2,124,055 | +2.0% | 36.73% | +31.8% |
| QDEL | Buy | QUIDEL CORP | $127,974,000 | +19.3% | 906,655 | +8.3% | 15.93% | +7.8% |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $51,413,000 | +54.1% | 1,181,357 | +67.5% | 6.40% | +39.2% |
| AGEN | Buy | AGENUS INC | $49,546,000 | -1.6% | 9,437,334 | +2.9% | 6.17% | -11.1% |
| OPK | OPKO HEALTH INC | $46,790,000 | -9.9% | 12,819,073 | 0.0% | 5.82% | -18.6% | |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $36,919,000 | -23.2% | 1,444,959 | +5.2% | 4.60% | -30.6% |
| AWH | ASPIRA WOMENS HEALTH INC | $28,103,000 | -42.2% | 8,647,094 | 0.0% | 3.50% | -47.8% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $27,601,000 | -9.1% | 1,920,733 | 0.0% | 3.44% | -17.9% | |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $21,869,000 | -28.1% | 3,751,121 | -0.7% | 2.72% | -35.1% |
| Sell | DERMTECH INC | $19,661,000 | -27.9% | 612,307 | -6.6% | 2.45% | -34.9% | |
| FORA | Buy | FORIAN INC | $12,384,000 | +13.5% | 1,199,960 | +38.2% | 1.54% | +2.5% |
| CDAK | Buy | CODIAK BIOSCIENCES INC | $11,431,000 | -9.1% | 700,000 | +3.1% | 1.42% | -17.9% |
| AVIR | New | ATEA PHARMACEUTICALS INC | $10,838,000 | – | 309,126 | +100.0% | 1.35% | – |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $9,008,000 | -11.4% | 315,642 | +5.0% | 1.12% | -20.0% |
| GH | New | GUARDANT HEALTH INC | $8,751,000 | – | 70,000 | +100.0% | 1.09% | – |
| ATRS | ANTARES PHARMA INC | $6,916,000 | -16.5% | 1,900,000 | 0.0% | 0.86% | -24.6% | |
| CFRX | CONTRAFECT CORP | $6,840,000 | -8.0% | 1,688,902 | 0.0% | 0.85% | -16.8% | |
| SEM | Buy | SELECT MED HLDGS CORP | $5,414,000 | +44.6% | 149,678 | +69.0% | 0.67% | +30.6% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $4,276,000 | +14.7% | 838,403 | -1.5% | 0.53% | +3.5% |
| IMMP | IMMUTEP LTDsponsored ads | $3,870,000 | 0.0% | 1,000,000 | 0.0% | 0.48% | -9.6% | |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $3,072,000 | – | 38,500 | +100.0% | 0.38% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $2,168,000 | – | 80,000 | +100.0% | 0.27% | – |
| MOTS | Sell | MOTUS GI HLDGS INC | $2,032,000 | -47.2% | 2,947,551 | -20.3% | 0.25% | -52.3% |
| SLNO | SOLENO THERAPEUTICS INC | $1,971,000 | -18.9% | 2,132,000 | 0.0% | 0.24% | -26.9% | |
| SPY | New | SPDR S&P 500 ETF TRput | $1,556,000 | – | 250,000 | +100.0% | 0.19% | – |
| BDSX | Sell | BIODESIX INC | $1,486,000 | -52.2% | 180,833 | -23.2% | 0.18% | -56.9% |
| VIR | New | VIR BIOTECHNOLOGY INCcall | $1,197,000 | – | 383,700 | +100.0% | 0.15% | – |
| PTIX | New | PROTAGENIC THERAPEUTICS INC | $935,000 | – | 500,000 | +100.0% | 0.12% | – |
| QQQ | New | INVESCO QQQ TRput | $895,000 | – | 300,000 | +100.0% | 0.11% | – |
| LLY | New | LILLY ELI & COcall | $680,000 | – | 100,000 | +100.0% | 0.08% | – |
| BIIB | BIOGEN INC | $683,000 | -18.2% | 2,412 | 0.0% | 0.08% | -26.1% | |
| VTNR | VERTEX ENERGY INC | $472,000 | -60.4% | 90,000 | 0.0% | 0.06% | -64.0% | |
| MDGL | New | MADRIGAL PHARMACEUTICALS INCcall | $426,000 | – | 63,000 | +100.0% | 0.05% | – |
| XBIT | New | XBIOTECH INC | $275,000 | – | 350,000 | +100.0% | 0.03% | – |
| SEM | New | SELECT MED HLDGS CORPcall | $193,000 | – | 26,100 | +100.0% | 0.02% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INCcall | $176,000 | – | 150,000 | +100.0% | 0.02% | – |
| OPK | New | OPKO HEALTH INCcall | $145,000 | – | 473,800 | +100.0% | 0.02% | – |
| PFE | New | PFIZER INCcall | $98,000 | – | 750,000 | +100.0% | 0.01% | – |
| AGEN | New | AGENUS INCcall | $53,000 | – | 100,000 | +100.0% | 0.01% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF INcall | $50,000 | – | 43,700 | +100.0% | 0.01% | – |
| OPK | Exit | OPKO HEALTH INCput | $0 | – | -667,800 | -100.0% | -0.05% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INCput | $0 | – | -196,700 | -100.0% | -0.18% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lput | $0 | – | -248,200 | -100.0% | -0.25% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -825,000 | -100.0% | -0.54% | – |
| CAPR | Exit | CAPRICOR THERAPEUTICS INC | $0 | – | -1,166,249 | -100.0% | -0.82% | – |
| XBI | Exit | SPDR SER TRs&p biotech | $0 | – | -76,200 | -100.0% | -1.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.